Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880685 · ClinicalTrials.gov registry record · Phase 2
Memantine in the Treatment of Kleptomania
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00880685 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 12 participants.
The verdict
NCT00880685, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of the proposed study is to evaluate the efficacy and safety of memantine in kleptomania.
Interventions
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00880685
The ClinicalTrials.gov registry entry for NCT00880685 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Memantine is the first listed.
NCT00880685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00880685 about?
NCT00880685 is a clinical study titled "Memantine in the Treatment of Kleptomania". The goal of the proposed study is to evaluate the efficacy and safety of memantine in kleptomania.
What is the current status of trial NCT00880685?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2009-03. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00880685?
The interventions under investigation include: Memantine (DRUG).
Who is sponsoring clinical trial NCT00880685?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.